About
Miles Congreve, PhD, is Chief Scientific Officer of Isomorphic Labs, the Alphabet-backed AI drug discovery company. He previously served as Chief Scientific Officer at Sosei Heptares and Director of Chemistry at Astex Pharmaceuticals, with earlier medicinal chemistry leadership experience at GlaxoSmithKline. Public profiles credit him with helping design 29 clinically evaluated drugs, co-inventing Kisqali (ribociclib), and serving on the Arctoris Scientific Advisory Board.
Areas of interest
AIdrug discoverybiotechmedicinal chemistrycomputational biologydigital biologyGPCR biologyfragment-based drug discoverystructure-based drug designoncology